Efficacy of rifampicin in eradication of carrier state of staphylococcus aureus in anterior nares with recurrent furunculosis

Journal of the College of Physicians and Surgeons Pakistan

Volumn 16, Issue 6, 2006, Pages 396-399

  Mashhood, Asher Ahmed ^a,c   Shaikh, Zafar Iqbal ^b   Qureshi, Shaukat Mehmood ^a   Malik, Sher Muhammad ^a  

^a Peshawar Cantonment   (Pakistan)

^b MILITARY HOSPITAL   (Pakistan)

^c CMH   (Pakistan)

Author keywords

Nasal carrier state; Recurrent furunculosis; Rifampicin; Staphylococcus aureus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; RIFAMPICIN;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; FURUNCULOSIS; HUMAN; INFECTION CONTROL; MALE; NOSE INFECTION; NOSE SMEAR; OUTPATIENT CARE; PAKISTAN; QUASI EXPERIMENTAL STUDY; RECURRENT INFECTION; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; CARRIER STATE; FEMALE; FURUNCULOSIS; HUMANS; MALE; MIDDLE AGED; NOSE; RECURRENCE; RIFAMPIN; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 33748433532     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet 2005; 5:751-62.
2. Krikler SJ. Staphylococcus aureus in Antarctica: carriage and attempted eradication. J Hyg (Lond) 1986; 97: 427-44.
3. Roodyn L. Epidemiology of staphylococcal infections. J Hyg (Lond) 1960; 58: 1-10.
4. Penneys MS. Skin manifestations of AIDS. London: Martin Dunitz, 1990.
5. Rebora A, Dallegri F, Patrone F. Neutrophil dysfunction and repeated infections: influence of levamisole and ascorbic acid. Br J Dermatol 1980; 102: 49-56.
6. Nobel WC. Microbial skin disease: its epidemiology. London: Arnold 1983.
7. Grimbacher B, Holland SM, Gallin JI. Hyper-IgE syndrome with recurrent infections: an autosomal dominant multisystem disorder. N Engl J Med 1999; 340: 692-702.
8. Valentine FCO, Hall-Smith SP. Superficial staphylococcal infection. Lancet 1953; ii: 351-4.
9. Nobel WC. Microbiology of human skin. 2nd ed. London: Lloyd-Luke 1981.
10. Hutchinson JGP, Green CA, Grimson TA. Nasal carriage of Staphylococcus aureus in nurses. J Clin Pathol 1957; 10: 546-9.
11. Millian SJ, Baldwin JN, Rheins MS. Studies on the incidence of coagulase-positive Staphylococci in a normal unconfined population. Am J Public Health 1960; 50: 791-8.
12. Spink M, Strong S. A possible hereditary factor in the nasal carriage of Staphylococci. Lancet 1966; i: 1337-9.
13. Bibel DJ, Aly R, Shinefield HR. Importance of keratinized epithelial cell in bacterial adherence. J Invest Dermatol 1982; 79:250-3.
14. Riechelmann H, Essig A, Deutschle T, Rau A, Rothermel B, Weschta M. Nasal carriage of Staphylococcus aureus in house dust mite, allergic patients and healthy controls. Allergy 2005; 60: 1418-23.
15. Kinsman OS, McKenna R, Nobel WC. Association between histocompatibility antigens (HLA) and nasal carriage of Staphylococcus aureus. J Med Microbiol 1983; 16: 215-20.
16. Anwar MS, Jaffery G, Bhatti K, Tayyib M, Bokhari SR. Staphylococcus aureus and MRSA nasal carriage in general population. J Coll Physicians Surg Pak 2004; 14: 661-4.
17. Erdenizmenli M, Yapar N, Senger SS, Ozdemir S, Yuce A. Investigation of colonization with methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population in Turkey. Jpn J Infect Dis 2004; 57: 172-5.
18. Nashev D, Toshkova K, Salasia SI, Hassan AA, Lammler C, Zschock M. Distribution of virulent genes of Staphylococcus aureus isolated from stable nasal carriers. FEMS Microbiol Lett 2004; 233: 45-52.
19. Pan ES, Diep BA, Charlebois ED, Auerswald C, Carleton HA, Sensabaugh GF. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus and their relation to community-associated disease activity. J Infect Dis 2005; 192: 811-8.
20. Leigh DA. Treatment of familial staphylococcal infection. J Antimicrob Chemother 1979; 5: 497-9.
21. Hernandez Vadell IT, Peraza TGT, Gonzalez M, Bonet IG. Methicillin-resistant Staphylococcus aureus. Detection of carriers among hospitalized children and healthy children from the community. Rev Cubana Med Trop 2003; 55: 153-61.
22. Hirschmann JV. Topical antibiotics in dermatology. Arch Dermatol 1988: 124: 1691-700.
23. Wheat LJ, Kohler RB, Luft FC, White A. Long-term studies on the effect of rifampicin on nasal carriage of coagulase-positive Staphylococci. Rev Infect Dis 1983; 5 (Suppl 3): S459-62.
24. Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy. JAMA 1988; 260: 2682-5.
25. Steel RW. Recurrent Staphylococcal infection in families. Arch Dermatol 1980; 116: 189-90.